CAU
ELV icon

Caxton Associates (UK)’s Elevance Health ELV Stock Holding History

Caxton Associates (UK)’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.27M Buy
+11,047
New +$4.1M 0.08% 100

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Caxton Associates (UK)'s ELV Position: Q2 2026 in Review

Caxton Associates (UK) opened a new position in Elevance Health (ELV) in Q2 2026: 11,047 shares worth $4.27M. The stake represents 0.08% of the portfolio and ranks #100 among its holdings.

1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Caxton Associates (UK) held 11,047 shares of Elevance Health worth $4.27M as of Q2 2026.
  • Elevance Health was a new Caxton Associates (UK) position in Q2 2026.
  • Elevance Health made up 0.08% of Caxton Associates (UK)'s portfolio in Q2 2026, its #100 holding.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.